Skip to content

Medifast MED Finished goods

Finished goods at other companies

Lifevantage Corporation logo
Lifevantage CorporationLFVN
$14.58M-22.5%
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Revenue$76.0M-34.3%
Gross profit$51.8M-38.6%
Operating income-$3.3M-161%
Net income-$2.1M-175%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$71.5M-22.0%
Total debt$16.1M+10.2%
Total equity$197.7M-6.3%
Total assets$252.0M-10.0%

Cash flow

See full
Operating cash flow$260.0K-92.4%
CapEx$1.1M-28.0%
Free cash flow-$836.0K-144%

Valuation

See full
Market cap$121.87M-17.4%
Enterprise value$66.44M+12.8%
P/S0.4×0.0×

Profitability

See full
Gross margin70.1%-3.8pp
Operating margin-4.7%-7.0pp
Net margin-5.8%-8.1pp
FCF margin5%-9.3pp

Returns & leverage

See full
Return on equity-9.8%-20.1pp
Debt / equity0.1×0.0×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medifast's finished goods?
Medifast (MED) reported finished goods of $16.49M in Q1 2026.
How has Medifast's finished goods changed year-over-year?
Medifast's finished goods decreased by 45.6% year-over-year, from $30.29M to $16.49M.
What is the long-term trend for Medifast's finished goods?
Over 5 years (2020 to 2025), Medifast's finished goods has grown at a -10.9% compound annual growth rate (CAGR), from $29.86M to $16.79M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.